Page last updated: 2024-08-24

xemilofiban and Diabetes Mellitus, Type 1

xemilofiban has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anders, RJ; Burns, DM; Cove, CS; DeFranco, AC; Ellis, SG; Kottke-Marchant, K; Lowrie, M; Miller, DP; Moliterno, DJ; Raymond, RE; Simpfendorfer, C; Sutton, JM; Topol, EJ1

Trials

1 trial(s) available for xemilofiban and Diabetes Mellitus, Type 1

ArticleYear
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions.
    Circulation, 1997, Jul-01, Volume: 96, Issue:1

    Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Benzamidines; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex

1997